Boorjian SA - Search Results

1

Development of a technique for evaluating the presence of malignant cells in prostatic fluid during robotic prostatectomy.

Lyon TD, Henry MR, Shah PH, Boorjian SA, Tollefson MK, Frank I. Lyon TD, et al. Among authors: boorjian sa. Urol Oncol. 2021 Mar;39(3):192.e1-192.e6. doi: 10.1016/j.urolonc.2020.08.007. Epub 2020 Aug 29. Urol Oncol. 2021. PMID: 32868191

2

Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy.

Blute ML, Boorjian SA, Leibovich BC, Lohse CM, Frank I, Karnes RJ. Blute ML, et al. Among authors: boorjian sa. J Urol. 2007 Aug;178(2):440-5; discussion 444. doi: 10.1016/j.juro.2007.03.121. Epub 2007 Jun 11. J Urol. 2007. PMID: 17561151

3

Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.

Boorjian SA, Thompson RH, Siddiqui S, Bagniewski S, Bergstralh EJ, Karnes RJ, Frank I, Blute ML. Boorjian SA, et al. J Urol. 2007 Sep;178(3 Pt 1):864-70; discussion 870-1. doi: 10.1016/j.juro.2007.05.048. Epub 2007 Jul 16. J Urol. 2007. PMID: 17631342

4

Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers.

Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Frank I, Blute ML. Boorjian SA, et al. BJU Int. 2008 Feb;101(3):299-304. doi: 10.1111/j.1464-410X.2007.07269.x. Epub 2007 Oct 8. BJU Int. 2008. PMID: 17922854

5

The role of partial nephrectomy for the management of sporadic renal angiomyolipoma.

Boorjian SA, Frank I, Inman B, Lohse CM, Cheville JC, Leibovich BC, Blute ML. Boorjian SA, et al. Urology. 2007 Dec;70(6):1064-8. doi: 10.1016/j.urology.2007.07.045. Urology. 2007. PMID: 18158015

6

Impact of obesity on clinicopathologic outcomes after robot-assisted laparoscopic prostatectomy.

Boorjian SA, Crispen PL, Carlson RE, Rangel LJ, Karnes RJ, Frank I, Gettman MT. Boorjian SA, et al. J Endourol. 2008 Jul;22(7):1471-6. doi: 10.1089/end.2008.0056. J Endourol. 2008. PMID: 18613784

7

T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival.

Boorjian SA, Sheinin Y, Crispen PL, Farmer SA, Lohse CM, Kuntz SM, Leibovich BC, Kwon ED, Frank I. Boorjian SA, et al. Clin Cancer Res. 2008 Aug 1;14(15):4800-8. doi: 10.1158/1078-0432.CCR-08-0731. Clin Cancer Res. 2008. PMID: 18676751

8

Advances in robotic prostatectomy.

Boorjian SA, Gettman MT. Boorjian SA, et al. Curr Urol Rep. 2008 May;9(3):250-6. doi: 10.1007/s11934-008-0043-y. Curr Urol Rep. 2008. PMID: 18765121

9

Surgical management of high risk prostate cancer: the Mayo Clinic experience.

Boorjian SA, Blute ML. Boorjian SA, et al. Urol Oncol. 2008 Sep-Oct;26(5):530-2. doi: 10.1016/j.urolonc.2008.03.009. Urol Oncol. 2008. PMID: 18774468 Review.

10

Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.

Boorjian SA, Heemers HV, Frank I, Farmer SA, Schmidt LJ, Sebo TJ, Tindall DJ. Boorjian SA, et al. Endocr Relat Cancer. 2009 Mar;16(1):123-37. doi: 10.1677/ERC-08-0124. Epub 2008 Oct 9. Endocr Relat Cancer. 2009. PMID: 18845648 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

544 results

Search Page

Filters